Severe COVID-19 in patients with immune-mediated rheumatic diseases: a stratified analysis from the SORCOM multicenter registry.

Alina BoteanuLeticia LeonSilvia Pérez EstebanElena Rabadán RubioMarina Pavía PascualGema BonillaCarmen Bonilla González-LaganáAntia García FernandezSheila Recuero DiazLucia Ruiz GutierrezJosé Javier Sanmartín MartínezNatalia de la Torre-RubioLaura NuñoOlga Sánchez PernauteIván Del BosqueLeticia Lojo OliveiraJosé Manuel Rodríguez HerediaDaniel ClementeLydia AbasoloJavier Bachiller-Corral

Published in: Modern rheumatology (2022)

This study confirms and provides new insights regarding the harmful effects of corticosteroids, rituximab and other therapies (mycophenolate and sulfasalazine) in COVID-19. Methotrexate and anti-TNF therapy were not associated with worse outcomes.

Keyphrases

coronavirus disease
sars cov
rheumatoid arthritis
diffuse large b cell lymphoma
type diabetes
cross sectional
clinical trial
adipose tissue
mesenchymal stem cells
drug induced
chronic lymphocytic leukemia